Suppr超能文献

血清中马尼地平的液相色谱电化学检测法

Liquid chromatographic determination of manidipine in serum with electrochemical detection.

作者信息

Ohkubo T, Uno T, Sugawara K

机构信息

Department of Pharmacy, Hirosaka University Hospital, Japan.

出版信息

J Chromatogr B Biomed Appl. 1996 Dec 13;687(2):413-8. doi: 10.1016/s0378-4347(96)00252-6.

Abstract

A highly sensitive and selective method for determining a dihydropyridine calcium antagonist, manidipine, by liquid chromatography using column switching with electrochemical detection was developed. Manidipine in serum was extracted by a rapid and simple procedure based on C8 bonded-phase extraction and then silica extraction. Manidipine and nilvadipine as an internal standard were separated on a C8 bonded-phase HPLC column and detected by high conversion efficiency amperometric detection at +0.7 V. Manidipine and nilvadipine (I.S.) were separated from an endogenous interference peak in serum and concentrated on a pre-column (C18) by column switching using an isocratic mobile phase, and then the corresponding fractions were introduced to an analytical column with a C8 stationary phase. Determination of manidipine was possible over the concentration range 0.5-10 ng/ml: the limit of detection was 0.3 ng/ml. The recovery of manidipine added to serum was 93.1-98.4% with coefficients of variation of less than 7.1%. The method is applicable to drug level monitoring in the serum of healthy volunteers treated with manidipine and to the analysis of pharmacokinetics.

摘要

建立了一种高灵敏度和选择性的液相色谱柱切换-电化学检测法测定二氢吡啶类钙拮抗剂马尼地平。血清中的马尼地平采用基于C8键合相萃取和硅胶萃取的快速简单方法进行提取。马尼地平和作为内标的尼伐地平在C8键合相HPLC柱上分离,并通过在+0.7 V下的高转换效率安培检测法进行检测。马尼地平和尼伐地平(内标)与血清中的内源性干扰峰分离,并使用等度流动相通过柱切换在预柱(C18)上浓缩,然后将相应的馏分引入具有C8固定相的分析柱。马尼地平在0.5-10 ng/ml的浓度范围内可进行测定:检测限为0.3 ng/ml。添加到血清中的马尼地平回收率为93.1-98.4%,变异系数小于7.1%。该方法适用于接受马尼地平治疗的健康志愿者血清中的药物浓度监测以及药代动力学分析。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验